DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/glsb97/head_and_neck) has announced the addition of the "Head and Neck Cancer Drug Pipeline Update 2013" report to their offering. There are today 133 companies plus partners developing 147 drugs targeting head and neck cancer in development. In addition,...
More...






